Mylan, J&J In Authorized Generics Deal Over Ditropan XL
Generic drug maker Mylan Laboratories and Johnson & Johnson subsidiary Alza have entered into an agreement over the rights to market a generic version of overactive bladder treatment Ditropan XL, adding...To view the full article, register now.
Already a subscriber? Click here to view full article